Answers are grounded in this paper and cite their sources.
Progress in deep learning is still a hurdle for the translation of clinical NLP models into deployable healthcare applications. Although the hybrid LLM-GNN models have demonstrated their ability in diagnostic tasks, there is a need to assess their capabilities in the conversational domain, computational efficiency, and validation for their practical application. This study builds upon a dual-modality architecture of Clinical-LLM-GNN that has been validated in previous studies, with two goals. First, we build a medical conversational AI system, in which we classify the intent (84.38% accuracy, 82.66% Macro F1 across 8 intents), recognize named entities (5 entity types), handle multi-turn dialogue (5-turn context), and generate responses based on the knowledge graph (8 diseases, 5 drugs), with a response time of 1.35ms. Second, we perform extensive validation by ablating studies (8 configurations), statistical testing (6 comparisons), and complexity analysis. The hybrid model BERT+GGNN+Attention excels in terms of accuracy (99.87%) with significant gains (p<0.05) over baselines, while retaining practical computational footprint (113.1M parameters, 47.3ms inference). The framework supports SDG 3 and SDG 9 by providing easy to use and scalable clinical decision support, which is a step towards deployment of conversational AI that improves clinical workflow and patient information access using foundation models.
No takes yet. Share an insight, caveat, or question.
Javagal et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: